Genovis nyemission fulltecknad

5/22/2012 5:06 EST
Emissionen tecknades i sin helhet varav 81 % tecknades med företräde. Genom emissionen tillförs Genovis 12,1 mSEK före emissionskostnader. Besked om tilldelning av aktier tecknade utan stöd av teckningsrätter kommer att ske genom utskick av avräkningsnotor den 22 maj 2012.
SE ALLA NYHETER

Genovis AB

Koncernen består av Genovis AB och dotterbolaget Eijdo research AB. Genovis utvecklar och säljer innovativa tekniker ur två unika produktportföljer. Den första innefattar nanoteknik i nya kontrastmedel och den andra best...

Visa mer


  KONTAKT  

Multimedia

GenovisQAprilSV
Sarah Fredriksson, VD, kommenterar bokslutsrapporten 2011
Delårsrapport jan-sep 2011

Extern feed

5/22/2012 5:11 EST
Genovis’ rights issue fully subscribed


Genovis’ rights issue fully subscribed
www.cisionwire.com
Genovis’ rights issue is fully subscribed and 81% of the shares are subscribed with preferential rights. The rights issue raised about SEK 12.1 million before issue expenses for Genovis. Statements of account will be sent on May 22, 2012, to allot...
5/21/2012 4:00 EST
Genovis launches FabRICATOR® 96-well plate for high throughput applications


Genovis launches FabRICATOR® 96-well plate for high throughput applications
www.cisionwire.com
Genovis is launching the FabRICATOR 96-well plate at the 2012 ASMS conference (May 19-24) in Vancouver, Canada, and the ADC Summit 2012 (May 23-24) conference in London. The FabRICATOR 96-well plate is standard format and fits most robotic...
5/20/2012 10:06 EST
Our booth (#160) at ASMS in Vancouver.

5/19/2012 2:08 EST
On our way to ASMS in Vancouver!

5/18/2012 4:18 EST
Genovis to publish Q2 2012 report ahead of schedule


Genovis to publish Q2 2012 report ahead of schedule
www.cisionwire.com
The Board of Directors of Genovis AB (publ) has decided to publish Q2 2012 report ahead of schedule. The Interim Report for January-June, which was to be announced on September 6, will be published ahead of schedule. The new publication date for...
5/10/2012 8:07 EST
Glöm inte teckna er i Genovis nyemission, idag är sista teckningsdag!
5/9/2012 3:30 EST
Five scientific poster from Genovis and our partners at Lund University.

5/9/2012 3:28 EST
A new exiting day at CLINAM conference in Basel!

4/25/2012 3:49 EST
INTERIM REPORT January – March 2012


INTERIM REPORT January – March 2012
www.cisionwire.com
Net sales totaled SEK 944k (455k), which is an increase of 107% compared with the first quarter of 2011. Loss after financial items was SEK 4,008k (loss: SEK 3,469k). Loss after tax was SEK 3,970k (loss: 3,458k). Earnings per share totaled SEK...
4/23/2012 4:49 EST
Genovis to publish Q1 2012 report ahead of schedule


Genovis to publish Q1 2012 report ahead of schedule
www.cisionwire.com
Genovis has decided to publish the report for Q1 2012 on Wednesday, April 25. The subscription period for Genovis’ rights issue is April 25 – May 10. Consequently, the Board of Directors for Genovis considers it to be important that...
3/21/2012 4:51 EST
GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) March 20, 2012


GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) March 20, 2012
www.cisionwire.com
The following decisions were adopted at the Annual General Meeting: The balance sheet and income statement were ratified. The Board of Directors and the CEO were discharged from liability. The Board shall consist of seven ordinary members with no...
3/19/2012 8:31 EST
Presenterar Genovis på Redeyes Investor Forum idag!
2/21/2012 3:01 EST
Aktiesparträffen i Ängelholm drog stor publik!

2/20/2012 6:00 EST
Årsstämma i Genovis AB (publ)


Årsstämma i Genovis AB (publ)
www.cisionwire.se
Aktieägare i Genovis AB (publ) kallas härmed till årsstämma tisdagen den 20 mars 2012 klockan 17:00, Scheelevägen 22 i Lund. 16.30 – 17.00 Registrering 17.00 Årsstämman inleds Efter stämman serveras en lättare förtäring
2/16/2012 3:53 EST
YEAR-END REPORT JANUARY-DECEMBER 2011


YEAR-END REPORT JANUARY-DECEMBER 2011
www.cisionwire.com
2011 in brief · Net sales climbed to SEK 2,856k (1,596k) · Revenues from the protein portfolio increased by 160% · Loss after financial items was SEK 13,758k (loss: 11,334k) · Comprehensive income for the year was SEK -13,608k (-11,292k) ...
2/14/2012 6:22 EST
VD Sarah Fredriksson presenterar bolaget hos Aktiespararna i Ängelholm den 16 februari klockan 19:00.
2/13/2012 5:07 EST
Genovis’ nanoparticle project published in prestigious Journal of Nuclear Medicine


Genovis’ nanoparticle project published in prestigious Journal of Nuclear Medicine
www.cisionwire.com
The first scientific article from the Sentinel Node project was published in the Journal of Nuclear Medicine, a highly ranked journal in its field and a forum for the exchange of clinical and scientific information for nuclear medicine practitioners.
2/7/2012 5:13 EST
Date change for Annual General Meeting and reports


Date change for Annual General Meeting and reports
www.cisionwire.com
The Board of Directors of Genovis AB (publ) has decided to hold the Annual General Meeting earlier on March 20, 2012. The notice convening the AGM will appear in Post och Inrikes Tidningar and an ad will be published in the newspaper Dagens Industri...
12/8/2011 4:59 EST
Last week Geneva, now US. Antibody characterization using our products is the topic of the day wherever we go!

11/24/2011 10:17 EST
Genovis AB nomination committee appointed


Genovis AB nomination committee appointed
www.cisionwire.com
As decided by the 2011 Annual General Meeting (AGM), a nomination committee has been appointed composed of: Mikael Lönn, holdings 22,26% Jörgen Wettbo represents 4,44% Torbjörn Fridh, holdings 3,11% Hans-Göran Arlock, holdings 1,26%
11/10/2011 2:30 EST
Delårsrapport januari-september 2011


Delårsrapport januari-september 2011
www.cisionwire.se
Finansiell information · Nettoomsättningen ökade med 100% till 1 932 (965) KSEK. · Resultatet efter finansnetto uppgick till -9 803 (-8 023) KSEK. · Resultatet efter skatt uppgick till – 9 771 (-7 991) KSEK. · Resultat per aktie -0,14...
8/26/2011 9:37 EST
Half-Yearly Report January-June 2011


Half-Yearly Report January-June 2011 | Cision Wire
www.cisionwire.com
Financial information · Net sales climbed to SEK 1,030k (558k) · Loss after financial items was SEK 6,784k (loss: 5,148k) · Loss after tax was SEK 6,763k (loss: 5,127k) · Earnings per share totaled SEK -0.10 (-0.12) · Cash and cash equivalents at the end of the period amounted to SEK 14,161k (1…
7/22/2011 3:01 EST
GENOVIS: COMMUNIQUÉ FROM EXTRA GENERAL MEETING, JULY 21, 2011


GENOVIS: COMMUNIQUÉ FROM EXTRA GENERAL MEETING, JULY 21, 2011 | Cision Wire
www.cisionwire.com
 
7/6/2011 7:17 EST
Notice of Extra General Meeting of Genovis AB (publ)


Notice of Extra General Meeting of Genovis AB (publ) | Cision Wire
www.cisionwire.com
A request of an Extra General Meeting has been received from a shareholder, holding more than 10 percent of the total shares in Genovis AB. The request the shareholder asks upon the Extra General Meeting is the item election of new board of directors in Genovis AB.
6/23/2011 3:36 EST
Genovis has a new majority owner


Genovis has a new majority owner | Cision Wire
www.cisionwire.com
 
6/23/2011 3:08 EST
GENOVIS HAR NY HUVUDÄGARE


GENOVIS HAR NY HUVUDÄGARE | Cision Wire
www.cisionwire.se
 
6/10/2011 5:24 EST
GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) June 9, 2011


GENOVIS: COMMUNIQUÉ FROM ANNUAL GENERAL MEETING FOR GENOVIS AB (PUBL) June 9, 2011 | Cision Wire
www.cisionwire.com
 
5/19/2011 3:03 EST
Nomination Committee Proposal for 2011 Board of Directors


Nomination Committee Proposal for 2011 Board of Directors | Cision Wire
www.cisionwire.com
The nomination committee for Genovis AB has notified the company that it will propose re-election of...